Biggest News Aggregation in the World
📰 Trident 1 News

Trident 1 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Trident 1. Real-time updates on events, politics, business and more.

Repotrectinib Sustains ORR, Safety in Locally Advanced or Metastatic ROS1+ NSCLC

Treatment with repotrectinib continued to produce high and durable responses with a manageable safety profile in patients with ROS1-positive locally advanced or metastatic non–small cell lung cancer who were naïve to a TKI or previously treated with 1 TKI and no chemotherapy.
South Korea Soult Ukpyolsi Joseph Fiore Byoung Chul Cho Cancer Laboratory Drug Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science